Antonio Calles, Head of the Lung Cancer Unit at Hospital Ruber Internacional, shared a post on X:
“Another intensification regimen improves clinical outcomes of patients with metastatic EGFRmut lung cancer.
This time with surgery/radiotherapy. NorhtStar randomized trial improved PFS regardless of type of mutation or number of metastases.”
More posts featuring Lung cancer.
